Document Detail


Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events.
MedLine Citation:
PMID:  20007159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: To determine whether changes in practice, over time, are associated with altered rates of major bleeding in acute coronary syndromes (ACS).
METHODS AND RESULTS: Patients from the Global Registry of Acute Coronary Events were enrolled between 2000 and 2007. The main outcome measures were frequency of major bleeding, including haemorrhagic stroke, over time, after adjustment for patient characteristics, and impact of major bleeding on death and myocardial infarction. Of the 50 947 patients, 2.3% sustained a major bleed; almost half of these presented with ST-elevation ACS (44%, 513). Despite changes in antithrombotic therapy (increasing use of low molecular weight heparin, P < 0.0001), thienopyridines (P < 0.0001), and percutaneous coronary interventions (P < 0.0001), frequency of major bleeding for all ACS patients decreased (2.6 to 1.8%; P < 0.0001). Most decline was seen in ST-elevation ACS (2.9 to 2.1%, P = 0.02). The overall decline remained after adjustment for patient characteristics and treatments (P = 0.002, hazard ratio 0.94 per year, 95% confidence interval 0.91-0.98). Hospital characteristics were an independent predictor of bleeding (P < 0.0001). Patients who experienced major bleeding were at increased risk of death within 30 days from admission, even after adjustment for baseline variables.
CONCLUSION: Despite increasing use of more intensive therapies, there was a decline in the rate of major bleeding associated with changes in clinical practice. However, individual hospital characteristics remain an important determinant of the frequency of major bleeding.
Authors:
Keith A A Fox; Kathryn Carruthers; Ph Gabriel Steg; Alvaro Avezum; Christopher B Granger; Gilles Montalescot; Shaun G Goodman; Joel M Gore; Ann L Quill; Kim A Eagle;
Related Documents :
9806109 - Abciximab. an updated review of its use in ischaemic heart disease.
9534319 - Mean-term calcium heparin treatment in acute transmural anterior myocardial infarction:...
19663529 - Cost effectiveness of fondaparinux in non-st-elevation acute coronary syndrome.
10827369 - Design of the blockade of the glycoprotein iib/iiia receptor to avoid vascular occlusio...
15580389 - Heparin-induced thrombocytopenia after coronary artery bypass grafting with cardiopulmo...
11489769 - Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionate...
22454659 - Systematic review of chinese herbal medicines for preventing in-stent coronary restenos...
16640709 - Bedside percutaneous transseptal mitral commissurotomy under sole transthoracic echocar...
7832599 - Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the el...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2009-12-08
Journal Detail:
Title:  European heart journal     Volume:  31     ISSN:  1522-9645     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-16     Completed Date:  2011-04-28     Revised Date:  2013-05-31    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  667-75     Citation Subset:  IM    
Affiliation:
Cardiovascular Research, Division of Medical and Radiological Sciences, The University of Edinburgh, Edinburgh, UK. k.a.a.fox@ed.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Coronary Syndrome / mortality,  therapy*
Aged
Aged, 80 and over
Angioplasty, Balloon, Coronary / adverse effects*,  trends
Coronary Artery Bypass / adverse effects*,  mortality
Female
Hematoma, Subdural / etiology
Hemorrhage / etiology*,  mortality,  prevention & control
Hospitalization
Humans
Kaplan-Meier Estimate
Male
Professional Practice / standards*,  trends
Prospective Studies
Recurrence
Registries
Stroke / etiology
Thrombolytic Therapy / adverse effects*,  mortality,  trends
Grant Support
ID/Acronym/Agency:
//British Heart Foundation
Comments/Corrections
Comment In:
Eur Heart J. 2010 Mar;31(6):640-1   [PMID:  20038514 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The interface between metabolic and stress signalling.
Next Document:  Low prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland.